(MENAFN- iCrowdNewsWire)

The Global CBD API Market growth is valued at US$521.94 Mn in 2024 and is expected to reach US$2233.37 Mn by 2034, with a CAGR of 15.8% during the forecast period of 2025-2034.

Latest Drivers, Restraint and Opportunities Market Snapshot:

Key factors influencing the global CBD API market are:

• Growing demand for organic health products
• Increasing awareness of healthcare
• Technological development

The following are the primary obstacles to the CBD API market's expansion:

• Lack of awareness
• Lack of consistent laws and regulations
• Elevated price of CBD products

Get Free Access to Demo Report, Excel Pivot and ToC:

Future expansion opportunities for the global CBD API market include:

• Growing innovative pharmaceuticals
• Expanding legal services and oversight in all Regions
• Increasing g research and development efforts

Key Industry Insights & Findings from the report:

• The proliferation of infectious diseases and the development of effective therapeutic cannabidiol (CBD) against them are driving forces behind this industry's expansion.
• Rising customer interest in tailored healthcare is anticipated to sustain the expansion of the CBD as an API industry.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• The market acceptance is expected to be hindered by the high costs related to the CBD as an API.

Market Analysis:

Cannabidiol (CBD), primarily extracted from the Cannabis sativa plant, is widely recognized for its therapeutic properties, including the potential to alleviate inflammation, stress, and tremors. The expanding legal authorization and increasing societal acceptance of CBD-based products are key factors driving market growth and production. Additionally, government support for medical research and strategic collaborations with leading industry stakeholders are anticipated to further propel the demand for CBD as an active pharmaceutical ingredient (API), reinforcing its prominence within the pharmaceutical and nutraceutical sectors.

Expert Knowledge, Just a Click Away:

List of Prominent Players in the CBD API Market:

• Recipharm
• Brains bioceutical
• Purisys
• DSM
• Bedrocan
• Vantage Hemp
• Eurofins
• BIOVECTRA Inc.
• EndoPure
• Biosyyd, UAB
• KD Pharma Group
• Folium Biosciences
• Kinetochem
• Colombian Golden
• Averix Bio, LLC
• Veranova
• KND Labs
• Jordan Process
• GVB Biopharma

Recent Developments:

• In March 2024, KD Pharma Group and health, wellness, and aesthetics entrepreneurs dsm-Firmenich announced that they would sell their Marine Lipids division to KD Pharma Group in return for minority ownership in the expanded KD company.
• In May 2024, Brains Bioceutical Corp is pleased to report a major advancement in the development of the initial stable Tetrahydrocannabinol (THC) as an API (an active pharmaceutical ingredient). This accomplishment shows the company's dedication to invention and its leadership in the marijuana pharmaceutical sector.
• In January 2025, Recipharm, a prominent worldwide contracting creation and production organization, declared that its latest flexible, clean filling system designed for medical availability, steer scale, and manufacturing expansion has become completely functional at its cutting-edge capacity in Wasserburg, Germany. Operating in complete accordance with GMP regulations, this sophisticated equipment carries out aseptic filling inside a Grade A isolator.

CBD API Market Dynamics

Market Drivers: Rising Demand for Natural Health Solutions

The cannabidiol (CBD) API market is being propelled by increasing consumer preference for natural and sustainable health products. CBD's perceived therapeutic benefits-such as alleviating chronic pain, reducing anxiety, and improving sleep quality-position it favorably compared to other plant-derived alternatives. Enhanced awareness and education regarding CBD's potential health advantages have further expanded its adoption across diverse sectors, including pharmaceuticals, nutraceuticals, cosmetics, and functional foods.

Challenges: Regulatory Inconsistencies and Legal Uncertainty

Market growth is constrained by the lack of uniform regulatory frameworks and inconsistent legal standards across different regions. As a derivative of the cannabis plant, CBD faces strict restrictions or outright prohibitions in several countries, particularly where permissible THC levels are not clearly defined. This regulatory ambiguity presents challenges for both manufacturers and consumers. Businesses may encounter difficulties in navigating complex legal requirements, while end-users may experience uncertainty regarding the legality, safety, and quality of CBD-containing products.

Unlock Your GTM Strategy:

North America Is Expected to Grow with The Highest CAGR During the Forecast Period

The North American CBD API market is projected to secure a substantial revenue share and demonstrate strong compound annual growth in the coming years. This growth is supported by advancements in pharmaceutical applications and the increasing integration of CBD into food, nutraceutical, and cosmetic products. Evolving consumer demographics, combined with widespread recognition of CBD's potential health benefits, are driving demand across diverse age groups and genders. As a result, expenditure on CBD-based products is expected to rise, reinforcing the region's leading position in the global market.

Segmentation of CBD API Market-

By Products-

• Full spectrum CBD
• Broad-spectrum CBD
• CBD isolate
• Water Dispersible CBD Powder
• Other Products

By Origin-

• Natural
• Synthetic

By Indication-

• Alzheimer's Disease
• Autism
• Cancer
• Chronic Pain
• Epilepsy
• Migraine
• Multiple Sclerosis
• Schizophrenia
• Other Indications

By End-Users-

• Pharmaceutical Industry
• Academic & Clinical Research Institutes

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Tags: CBD API Market See Campaign:
Contact Information:

Contact us: InsightAce Analytic Pvt. Ltd. Visit: Tel : +1 607 400-7072 Asia: +91 79 72967118 ...

Tags:
CE , Go Media , Go Media2 , iCN Internal Distribution , Reportedtimes , Research Newswire , English

MENAFN01102025003318003403ID1110139320